Filtered By:
Source: The Journal of Clinical Endocrinology and Metabolism
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 115 results found since Jan 2013.
SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes
J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210/clinem/dgad113. Online ahead of print.ABSTRACTBACKGROUND: SGLT2 inhibitors (sodium-glucose cotransporter-2 inhibitors) have recently been recommended as preferred agents for management of hyperglycemia in type 2 diabetes, primarily based on their ability to reduce a composite of major cardiovascular adverse events (3P MACE), predominantly by reducing cardiovascular death. However reduction of the individual components, myocardial infarction (MI) or stroke (fatal and non-fatal) events have not been well explored.METHODS: In this meta-analysis, we included data avail...
Source: The Journal of Clinical Endocrinology and Metabolism - March 1, 2023 Category: Endocrinology Authors: Pradip Mukhopadhyay Debmalya Sanyal Purushottam Chatterjee Kaushik Pandit Sujoy Ghosh Source Type: research
Insulin-like Growth Factor 1 and Risk of Cardiovascular Disease: Results from the UK Biobank Cohort Study
CONCLUSION: This study indicates that both low and high levels of circulating IGF-1 are associated with increased risk of CVD in general population. These results highlight the importance of monitoring IGF-1 status on cardiovascular health.PMID:36810801 | DOI:10.1210/clinem/dgad105
Source: The Journal of Clinical Endocrinology and Metabolism - February 22, 2023 Category: Endocrinology Authors: Jiayang Lin Linjie Yang Junlin Huang Yating Liu Xuzhen Lei Ruxin Chen Bingyan Xu Chensihan Huang Weijuan Dou Xueyun Wei Deying Liu Peizhen Zhang Yan Huang Zhimin Ma Huijie Zhang Source Type: research
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
CONCLUSION: GLP-1RAs, precisely longer acting formulations, reduced ischemic cerebrovascular events in T2DM. Observed benefits were significantly higher in patients with shorter T2DM duration and higher eGFR.PMID:36800286 | DOI:10.1210/clinem/dgad076
Source: The Journal of Clinical Endocrinology and Metabolism - February 17, 2023 Category: Endocrinology Authors: Mainak Banerjee Rimesh Pal Satinath Mukhopadhyay Kirthana Nair Source Type: research
Association of urinary nitrate with diabetes complication and disease-specific mortality among adults with hyperglycemia
CONCLUSIONS: Higher urinary nitrate is associated with lower risk of congestive heart failure and diabetic nephropathy, and lower risk of all-cause, CVD, and diabetes mortalities. These findings indicated that inorganic nitrate supplementation can be considered as a supplementary treatment for people with hyperglycemia.PMID:36576885 | DOI:10.1210/clinem/dgac741
Source: The Journal of Clinical Endocrinology and Metabolism - December 28, 2022 Category: Endocrinology Authors: Wenbo Jiang Jia Zhang Ruiming Yang Xinyi Sun Huanyu Wu Jiacheng Zhang Siyao Liu Changhao Sun Lifang Ma Tianshu Han Wei Wei Source Type: research
Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes
J Clin Endocrinol Metab. 2022 Dec 27:dgac750. doi: 10.1210/clinem/dgac750. Online ahead of print.ABSTRACTBACKGROUND: Proton pump inhibitors (PPIs) are widely used drugs for gastric-acid-related diseases, which may have an impact on the gut microbiome. We aimed to evaluate the associations of PPI use with risks of cardiovascular disease (CVD) and all-cause mortality in patients with type 2 diabetes (T2D).METHODS: We analysed the associations of PPI use with risks of coronary artery disease (CAD), myocardial infarction (MI), heart failure (HF), stroke, and all-cause mortality in 19,229 adults with T2D using data from the UK ...
Source: The Journal of Clinical Endocrinology and Metabolism - December 27, 2022 Category: Endocrinology Authors: Tingting Geng Jun-Xiang Chen Yan-Feng Zhou Qi Lu Zhenzhen Wan Liegang Liu An Pan Gang Liu Source Type: research
Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study
CONCLUSION: Our findings provide novel evidence that genetically determined diabetes subgroups by age at diagnosis have similar causal effects on CVD and cardiometabolic risks.PMID:36373429 | DOI:10.1210/clinem/dgac658
Source: The Journal of Clinical Endocrinology and Metabolism - November 14, 2022 Category: Endocrinology Authors: Chaojie Ye Lijie Kong Yiying Wang Hong Lin Shuangyuan Wang Zhiyun Zhao Mian Li Yu Xu Jieli Lu Yuhong Chen Min Xu Weiqing Wang Guang Ning Yufang Bi Tiange Wang Source Type: research
